OUTCOMES
Follow‐up periods	List all follow‐up periods given in report
Total no. of randomized participants	Participants in experimental group				Participants in control group
Primary outcomes
(dichotomous 'end point' outcome)		Participants analysed		Number of events in the groups: E = experimental C = control			Bias of the outcome
All‐cause mortality	Maximum follow‐up	E (n)		E (n)			L / U / H
		C (n)		C (n)
	End of trial intervention period	E (n)		E (n)			L / U / H
		C (n)		C (n)
Serious adverse events: Nb. Number of counts. If SAE is reported, list them individually	Maximum follow‐up	E (n)		E (n)			L / U / H
		C (n)		C (n)
	End of trial intervention period	E (n)		E (n)			L / U / H
		C (n)		C (n)
(continuous outcome)		Participants analysed	Mean (endpoint or change)			SD	Bias of the outcome
Quality of life: Type of QoL scale:	Maximum follow‐up	E (n)	E			E	L / U / H
		C (n)	C			C	L / U / H
	End of trial intervention period	E (n)	E			E	L / U / H
		C (n)	C			C	L / U / H